Kojic Acid Peptide: A New Compound with Anti-Tyrosinase Potential
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Kojic acid was used for decades in the cosmetic industry as an antimelanogenic agent. However, there are two major drawbacks of Kojic acid, one is cytotoxicity and second are instability on storage. These limitations led the scientist to synthesize the active Kojic acid peptides. Objective: In the present study, we synthesize and investigate the effect of five Kojic acid peptides to overcome the limitation of Kojic acid. Methods: The peptide was analyzed and purified by high-performance liquid chromatography and matrix-assisted laser desorption ionization time of flight mass spectroscopy. Further, the tyrosinase activities of the Kojic acid and Kojic acid peptides were compared. The toxicity was measured and the melanin content is recorded in B16F10 mouse melanoma cells. Results: Maximum tyrosinase activity was measured by Kojic acid peptides. Therefore, Kojic acid peptides were subjected to melanin assay and cytotoxicity assay and finally the stability of the Kojic acid peptide was measured. Conclusion: It was observed that this newly synthesized Kojic acid peptide is stable and potent to inhibit the tyrosinase activity and melanin content of B16F10 mouse melanoma cells without exhibiting cell toxicity. Together, these preliminary results suggest that a further exploration is being needed to establish Kojic acid peptide as antimelanogenic agent.
Abstract
Background: Kojic acid was used for decades in the cosmetic industry as an antimelanogenic agent. However, there are two major drawbacks of Kojic acid, one is cytotoxicity and second are instability on storage. These limitations led the scientist to synthesize the active Kojic acid peptides. Objective: In the present study, we synthesize and investigate the effect of five Kojic acid peptides to overcome the limitation of Kojic acid. Methods: The peptide was analyzed and purified by high-performance liquid chromatography and matrix-assisted laser desorption ionization time of flight mass spectroscopy. Further, the tyrosinase activities of the Kojic acid and Kojic acid peptides were compared. The toxicity was measured and the melanin content is recorded in B16F10 mouse melanoma cells. Results: Maximum tyrosinase activity was measured by Kojic acid peptides. Therefore, Kojic acid peptides were subjected to melanin assay and cytotoxicity assay and finally the stability of the Kojic acid peptide was measured. Conclusion: It was observed that this newly synthesized Kojic acid peptide is stable and potent to inhibit the tyrosinase activity and melanin content of B16F10 mouse melanoma cells without exhibiting cell toxicity. Together, these preliminary results suggest that a further exploration is being needed to establish Kojic acid peptide as antimelanogenic agent.
참고문헌 (22)
- Jones G, "Beauty imagined : a history of the global beauty industry" (2010), Oxford University Press
- Noh JM., "Kojic acid-tripeptide amide as a new tyrosinase inhibitor", Biopolymers, 88, pp.300~307 (2007)
- Slominski A., "Melanin pigmentation in mammalian skin and its hormonal regulation", Physiol Rev, 84, pp.1155~1228 (2004)
- Breathnach AC., "Azelaic acid therapy in disorders of pigmentation", Clin Dermatol, 7, pp.106~119 (1989)
- Verallo-Rowell VM., "Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma", Acta Derm Venereol Suppl(Stockh), 143, pp.58~61 (1989)
- Jimbow K, "N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma", Arch Dermatol, 127, pp.1528~1534 (1991)
- Neering H, "Treatment of melasma(chloasma)by local application of a steroid cream", Dermatologica, 151, pp.349~353 (1975)
- Griffiths CE., "Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled., clinical trial", Br J Dermatol, 129, pp.415~421 (1993)
- Kimbrough-Green CK., "Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial", Arch Dermatol, 130, pp.727~733 (1994)
- Lima LL., "Azastilbene analogs as tyrosinase inhibitors : new molecules with depigmenting potential", ScientificWorldJournal, 2013, pp.274643~ (2013)
- Saghaie L., "Synthesis and tyrosinase inhibitory properties of some novel derivatives of kojic acid", Res Pharm Sci, 8, pp.233~242 (2013)
- Schurink M., "Novel peptides with tyrosinase inhibitory activity", Peptides, 28, pp.485~495 (2007)
- Chen JS., "Inhibition mechanism of kojic acid on polyphenol oxidase", J Agric Food Chem, 39, pp.1897~1901 (1991)
- Kobayashi Y., "Synthesis of amino acid derivatives of kojic acid and their tyrosinase inhibitory activity", Biosci Biotech Biochem, 59, pp.1745~1746 (1995)
- Kadokawa J., "Synthesis of kojic acid derivatives containing phenolic hydroxy groups", Commun, 33, pp.1081~1086 (2003)
- Kitano T., "Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy", Int J Hematol, 86, pp.37~41 (2007)
- Manga P., "Inverse correlation between pink-eyed dilution protein expression and induction of melanogenesis by bafilomycin A1", Pigment Cell Res, 14, pp.362~367 (2001)
- Kubo I., "Tyrosinase inhibitory activity of the olive oil flavor compounds", J Agric Food Chem, 47, pp.4574~4578 (1999)
- Luo LH., "Depigmentation of melanocytes by(2Z, 8Z)-matricaria acid methyl ester isolated from Erigeron breviscapus", Biol Pharm Bull, 32, pp.1091~1094 (2009)
- Park S., "Unrevealing the role of P-protein on melanosome biology and structure, using siRNA-mediated down regulation of OCA2", Mol Cell Biochem, 403, pp.61~71 (2015)
- Artursson P., "Caco-2 monolayers in experimental and theoretical predictions of drug transport", Adv Drug Deliv Rev, 46, pp.27~43 (2001)
- Yoon M., "Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results", Crit Rev Toxicol, 42, pp.633~652 (2012)